Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients
Clinical trial NCT03382795 · UNKNOWN
Trial details
- NCT number
- NCT03382795
- Sponsor
- Korea University Guro Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-03
- Primary completion
- 2023-03-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.